Mouse Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Protein (Active)

Este producto es parte de TNFRSF9 - TNF receptor superfamily member 9
Product Graph
1118€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Mouse Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Protein (Active)
category
Proteins and Peptides
provider
Abbexa
reference
abx690913
tested applications
SDS-PAGE

Description

Mouse CD137 Protein is a recombinant protein from Mouse produced in HEK293 Cells. A DNA sequence encoding the mouse TNFRSF9 (NP_001070976.1) (Met 1-Leu 211) was fused with the Fc region of human IgG1 at the C-terminus.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
CD137
Host
HEK293 cells
Assay Type
Activity: Active
Sequence Fragment: Met1-Leu211
Tag: C-terminal Fc tag
Origin
Mouse
Observed MW
47 kDa
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Size 1
100 µg
Size 2
1 mg
Form
Lyophilized
Tested Applications
SDS-PAGE
Buffer
Lyophilized from sterile PBS, pH 7.4.
Availability
Shipped within 5-15 working days.
Storage
Storage: Store lyophilized between -20 °C and -80°C.
Stability: Stable when stored reconstituted at 2-8°C for up to 1 week. Reconstituted aliquots are stable at -20°C for up to 3 months.
Shelf Life: 12 months.
Dry Ice
No
NCBI Accession
NP_001070976.1
Alias
Tumor necrosis factor receptor superfamily member 9,ILA,4-1BB,CD137,CDw137,IMD109,4-1BB ligand receptor,T-cell antigen 4-1BB homolog,T-cell antigen ILA
Background
Protein TNFRSF9
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Endotoxin Level: < 1.0 EU per µg of the protein as determined by the LAL method.

Descripción

TNFRSF9, also known as 4-1BB or CD137, is a member of the tumor necrosis factor receptor (TNFR) superfamily and plays a key role in immune regulation. This receptor is expressed primarily on activated T cells, as well as on natural killer (NK) cells, dendritic cells, and some other immune cell types, particularly after stimulation. It serves as a co-stimulatory receptor, enhancing T-cell proliferation, survival, and effector function, making it pivotal in immune responses and antitumor immunity. TNFRSF9 has gained attention as a therapeutic target in cancer immunotherapy due to its role in enhancing immune cell activation and persistence. Upon binding with its ligand, TNFSF9 (also known as 4-1BB ligand or 4-1BBL), TNFRSF9 undergoes trimerization, which is essential for transmitting downstream signaling. This receptor’s functions extend beyond tumor immunity; it is also involved in chronic inflammation and autoimmune diseases, and as such, modulation of TNFRSF9 signaling has therapeutic implications across several pathologies.

Related Products

EH0312

Human TNFRSF9/4-1BB (Tumor necrosis factor receptor superfamily member 9) ELISA Kit

Ver Producto
EH0312-CM

Human TNFRSF9/4-1BB (Tumor necrosis factor receptor superfamily member 9) ELISA Kit

Ver Producto
EM0193

Mouse TNFRSF9/4-1BB (Tumor necrosis factor receptor superfamily member 9) ELISA Kit

Ver Producto